rethinkPeptides Search
Menu
Study breakdown

Cold plasma activates masked cell-penetrating peptides for precise drug delivery with spatial control

evidence
The takeaway

A cold atmospheric plasma-responsive delivery system masks cell-penetrating peptides with DNA nanostructures until externally activated, enabling precise spatial and temporal control of peptide-mediated drug delivery.

External on-switch for peptides

Cold plasma selectively activates masked cell-penetrating peptides, providing spatial and temporal control over drug delivery

What the researchers found

DNA nanoflower structures (150-250 nm) masked CPP activity under physiological conditions. Cold plasma treatment disrupted DNA masking and restored peptide function. Fluorescence recovery, cellular uptake, and cytotoxicity all controllable by plasma activation in 2D and 3D models.

Why it matters

Uncontrolled cell penetration is the main limitation of CPP-based drug delivery. This system solves it by providing an external "on switch" that activates the peptide only where and when needed, potentially reducing side effects of peptide-delivered drugs.

How the study worked

DNA nanoflower synthesis and TEM characterization, structural/functional analysis, fluorescence recovery assays, cellular uptake studies, cytotoxicity measurements in monolayer and 3D spheroid models, cold plasma activation.

What this study cannot tell us

Proof of concept only—no in vivo data. Cold plasma has limited tissue penetration depth. Clinical applicability of external plasma activation needs evaluation. Manufacturing scalability unclear.

How to read the evidence

In vitro proof of concept with 2D and 3D validation. Innovative platform but lacks in vivo data.

When this study was published

Published in 2025.

The bigger picture

This represents a broader shift toward "smart" peptide therapeutics that can be activated on demand. The modular platform could be applied to various therapeutic peptides, enabling precision medicine approaches where drug activation is spatially and temporally controlled.

Questions still open

  • Can cold plasma penetrate deeply enough for clinical applications?
  • How long does the CPP remain active after plasma activation?
  • Could other external triggers (light, ultrasound) be adapted for this platform?

Common questions

What are cell-penetrating peptides?
Cell-penetrating peptides (CPPs) are short peptide sequences that can cross cell membranes and carry therapeutic cargo inside cells. Their main limitation is that they penetrate all cells indiscriminately, causing off-target effects. This system solves that by keeping them masked until activated.
What is cold atmospheric plasma?
Cold plasma is an ionized gas produced at room temperature that can be applied to biological tissues without thermal damage. In this system, it serves as an external trigger that breaks apart DNA nanostructures masking the peptides, activating them precisely where the plasma is applied.

Read the original research

Externally Triggered Activation of Nanostructure-Masked Cell-Penetrating Peptides.

Molecules (Basel, Switzerland), 30(15)

Citation

Shim, Gayong. (2025). Externally Triggered Activation of Nanostructure-Masked Cell-Penetrating Peptides.. Molecules (Basel, Switzerland), 30(15). https://doi.org/10.3390/molecules30153205